PharmaGo Hosts CPHI 2026 Forum on Small Molecule Drug Discovery and Design in Shanghai on June 16

May 28, 2026 16:06 CST Updated 16:06

MingMed

Innovative Drug Developer

As one of the key concurrent conferences of the 2026 CPHI China (CPHI China),The "Small Molecule New Drug Discovery and Design Forum", hosted by Yadu, will be held on June 16 at Conference Room M20, Hall E2, Shanghai New International Expo Centre (Pudong).

This edition of CPHI brings together the leading forces across the global pharmaceutical industry chain. As a core pillar of drug R&D, small-molecule novel drugs are ushering in a new wave of innovation spanning from target discovery to clinical translation. This forum focuses on cutting-edge frontiers such as bifunctional molecules, highly selective kinase inhibitors, TLR7/8 dual agonists, and AI-designed oral GLP-1, dedicated to establishing an efficient dialogue platform bridging industry and academia.

Meeting Time |2026June 16 13:30-16:30

Venue |Part IMeeting Room M20, Hall E2, Shanghai New International Expo Centre (Pudong)

Host |China Chamber of Commerce for Import and Export of Medicines & Health Products, Informa Markets (Shanghai) Co., Ltd., Yadu Group

Long press to scan the QR code above.

Before 00:00 on June 12Limited-Time Free Ticket Claim

`Secure Limited Conference Seats`

Preview of the Thematic Forum Highlights

?Sharing Cutting-Edge Achievements

Interpreting the latest R&D advances and clinical application outcomes in the field of novel small-molecule drug discovery and design, and conveying the industry's innovation directions.

?Breaking Through R&D Bottlenecks

Centered on the end-to-end workflow of small-molecule drug discovery and design, this discussion explores the core challenges facing the industry and corresponding solutions to drive industrial implementation.

? Establish a Communication Platform

Integrate multiple stakeholders across industry, academia, research, and application to facilitate resource sharing, collaboration, and talent exchange, accelerate the translation and commercialization of research outcomes, and build a complete industrial chain ecosystem.

? Guiding the Development Direction

Interpret policy directions and industry trends in the field of small-molecule novel drug discovery and design, analyze the potential of niche segments, and provide precise reference.

? Driving Clinical Implementation

Focusing on clinical needs in the discovery and design of novel small-molecule drugs, exploring the clinical application value of innovative achievements, and advancing the translational development of new drugs.

Full Conference Process: AdvanceSeize the Opportunity for Exchange

13:30-14:00

Advances in the Research and Development of Bifunctional Small-Molecule Drugs

Xie YuliChairman, Weijing Biotechnology

14:00-14:30

TBD

14:30-15:00

Design and Development of Novel Small-Molecule Dual TLR7/8 Agonists

Liao XuebinMingMed Chief Scientist

15:00-15:30

Precision Design of Highly Selective Kinase Inhibitors: Differentiated Breakthroughs from FGFR2 to CDK4/6 (Tentative)

Hu ShaojingSikang Ruiqi Chairman

15:30-16:00

AI-Designed Oral GLP-1: Phase III Progress and Translational Value

Lin Jian MindRank Chief Commercial Officer

16:00-16:30

Realistic Virtualization: Research and Development of Dual-Target Small-Molecule Drugs

Li JingChairman, Yadu Group

Last Seats Available! Scan QR Code to Secure

Conference seat reservations have now entered the "final sprint to secure" phase., if you wish to ask questions, interact on-site, and engage in in-depth discussions with the guests, please scan the QR code to register promptly!

Long press to scan the QR code above

Limited-Time Free Ticket Registration Before 00:00 on June 12

Secure Limited Conference Seats

Booth No. E7A26,Yadu & Jingyu Joint Exhibition!

In addition to the insightful forum presentations,YaduAs a key participant in this forum, [we] will also2026 CPHI On-site andJingyu GroupJointly set up a booth.

Booth No.: E7A26
Exhibition Dates: June 16-18
Important Notice: The closing keynote speaker of the forum, Dr. Li Jing, Chairman of Yadu Group, will deliver a presentation on 《Reality-Based Virtualization: R&D of Dual-Target Small Molecule Drugs》 from 16:00 to 16:30 on the afternoon of the 16th. You are welcome to attend the forum first before proceeding toBooth E7A26Continue in-depth discussions with the Yadu team to learn more about data-driven solutions for new drug discovery.
June 16, Shanghai: Join leading experts in new drug R&D to explore cutting-edge technologies and shape an innovative future! We cordially invite industry professionals to attend and jointly embark on a new journey in small-molecule new drug development!